TiMinCeBIL Profile Banner
Timo Minssen Profile
Timo Minssen

@TiMinCeBIL

Followers
1K
Following
4K
Media
108
Statuses
2K

Law Prof.,⚖️🦠🧬🤖💊 @CeBIL_Center Dir.,@uni_copenhagen, @cambridgelaw Affiliate, Advisor @EUofficio, ❤️Blues #AI #Biomed #Data #Regulation #IPR #HealthLaw

Lund
Joined February 2015
Don't wanna be here? Send us removal request.
@TiMinCeBIL
Timo Minssen
3 days
🔒 New in npj Digital Medicine: “Quantum cryptography and data protection for medical devices post & pre Q-Day”. By Oscar Freyer, Max Ostermann, Timo Minssen & Stephen Gilbert 👉 https://t.co/knuxHAMORO #QuantumComputing #Cybersecurity #DigitalHealth #MedTech #Cryptography
Tweet card summary image
nature.com
npj Digital Medicine - Although still at a nascent state, quantum computing promises advances in healthcare, from drug discovery to personalised treatments. But it also threatens current...
0
0
1
@TiMinCeBIL
Timo Minssen
8 days
I’m delighted to share our new empirical ”open access” article:“A #Global #Landscape of #Patenting Activity in #COVID-19 #Vaccines”, freely available here: https://t.co/d0m32nJ164 @CeBIL_Center
0
0
1
@TiMinCeBIL
Timo Minssen
1 month
📢 New in @AmJLMed ! Our article “Statutory Thickets & Drug Shortages: Accumulating Legislation as an Underlying Cause” explores how decades of well-intended laws have unintentionally fueled drug shortages. 🔗 https://t.co/uuyYUzBJT1 #DrugShortages #HealthLaw #PharmaPolicy
Tweet card summary image
cambridge.org
Statutory Thickets and Drug Shortages: Accumulating Legislation as an Underlying Cause - Volume 51 Issue 2
0
0
2
@TiMinCeBIL
Timo Minssen
3 months
“IP in Superposition: #Patents, #Trade #Secrets, and #Open #Innovation in #Quantum #Information #Technology”.“ Co-authored with my splendid colleagues Gabriela Lenarczyk & Mateo Aboy, it is now available on SSRN here:
0
0
2
@TiMinCeBIL
Timo Minssen
4 months
📢 Delighted about our recent publication in "Expert Review of Medical Devices" on regulatory challenges in multi-country data-driven projects developing & validating #medical #AI systems with E.Niemiec, P.Boland, P.McEntee, @.Cahill & myself. Available @:
tandfonline.com
Many legal and regulatory requirements need to be considered in projects developing medical AI systems. Their implementation may be challenging as both AI technology and some of the regulations are...
0
4
11
@MSFTResearch
Microsoft Research
4 months
In “AI Testing & Evaluation,” professors Daniel Carpenter & Timo Minssen explore pharma & medical device regulation, including the role of clinical trials, while Microsoft’s Chad Atalla shares where AI governance stakeholders might find inspiration. https://t.co/veOh7psOSg
0
7
38
@DrSinhaEsq
Michael Sinha
4 months
In Geneva this week for the IP Researchers Europe #IPRE conference! Looking forward to presenting early progress on a new project with @TiMinCeBIL @CeBIL_Center @UCPH_Research titled "Novel Diagnostics, Vaccines, and Therapeutics for Pandemics: A Call for Proportionality"
0
3
4
@CeBIL_Center
CeBIL
5 months
Join Prof. @WNicholsonPrice on 19 June (11:00–12:00) for a seminar on Governance mechanisms, acceptability, and trust in medical AI 📍UCPH + Zoom More info & Registration: https://t.co/wIHxLQSmc7 🔔 Limited seats on-site! @TiMinCeBIL @UCPH_Research @novonordiskfond @MarceloCorCom
0
2
5
@CeBIL_Center
CeBIL
6 months
AMR is an environmental issue too. We're kicking off #EarthDay with a new EP of #UnpackingAMR ft. @IsaacWeldon & Ilaria Natalia, exploring the socio-ecological dynamics of #AMR and shifting the narrative from a war on microbes to coexistence. Listen here: https://t.co/sZwLNRYS7y
0
1
1
@PetrieFlom
Petrie-Flom Center
6 months
We are five posts into a special digital symposium about artificial intelligence in medicine. Edited by @TiMinCeBIL & @MarceloCorCom at @UCPH_Research, supported by a generous scientifically independent grant from the @novonordiskfond: https://t.co/rs4BGoMP3W
0
3
2
@classicaproject
CLASSICA
7 months
🏥 We are proud to announce the successful launch of CLASSICA-OR at @Beaumont_Dublin! Prof John Burke and his team performed the first surgery using our #AI for real-time #ColorectalCancer classification in situ 🔗 Read more https://t.co/PbeRUdpQ2v 🎥 Hear from @MaterSurgery 👇
0
5
13
@classicaproject
CLASSICA
8 months
🚨 The EU AI Act is now in effect, bringing the world’s first comprehensive AI regulation—with major implications for U.S. health care & medical AI. 🏥🤖 A new @classicaproject @NEJM_AI article by Dr Sebastian Porsdam Mann, Prof. I. Glenn Cohen, & Prof. @TiMinCeBIL Minssen
0
3
4
@classicaproject
CLASSICA
8 months
🚨 Join us at the Life Sciences AI Summit! 📅 26 March 2025 | Brussels ⚡ "CLASSICA Case Study: Bringing AI Into the Surgery Room: Medical, Ethical, and Legal Challenges" organised by @TiMinCeBIL & @gerke_sara 🔗 Register https://t.co/9YYGAxM5cU #HorizonEU #LifeSciencesAI
0
4
6
@classicaproject
CLASSICA
7 months
📚 Knowledge Unwrapped: Understanding "Guidelines for ethical use and acknowledgement of large language models in academic writing" by Sebastian Porsdam Mann @CeBIL_Center et al 🤝 Practical guidance for acknowledging LLMs in academic writing https://t.co/aeJT8x3Zox #HorizonEU
@classicaproject
CLASSICA
9 months
📚 This new @classicaproject publication in @NatMachIntell 📚 introduces ethical criteria for using large language models (#LLMs) in research. It also provides a statement researchers can include in AI-assisted manuscripts to confirm compliance. With concerns about AI-generated
0
3
5
@CeBIL_Center
CeBIL
8 months
@TiMinCeBIL, Director of CeBIL, has joined the Editorial Board of the @JIPLP -Journal of Intellectual Property Law & Practice (Oxford University Press). 📖 Read more: https://t.co/cML8AdvAnM -- #IntellectualProperty #IPLaw #AcademicPublishing #CeBIL #JIPLP #OxfordUniversityPress
Tweet card summary image
jura.ku.dk
1
1
1
@TiMinCeBIL
Timo Minssen
9 months
2
1
12
@TiMinCeBIL
Timo Minssen
11 months
Delighted to see our collaborative @bioethics_net (AJOB) Target Article led by @casparbarnes123 & Sebastian Porsdam Mann et al. published. The full article: “Enabling Demonstrated Consent for Biobanking with Blockchain and Generative AI” is available here:
Tweet card summary image
tandfonline.com
Participation in research is supposed to be voluntary and informed. Yet it is difficult to ensure people are adequately informed about the potential uses of their biological materials when they don...
1
1
5
@CTS_FGV
CTS-FGV
11 months
📌 Confira o cronograma detalhado do workshop "Algorithmic Dreams Meet Competition Law and Regulation: Promoting Responsible Innovation"!
1
2
2
@CTS_FGV
CTS-FGV
11 months
Session 2: Digital Health: Competition Law, Regulation, Innovation policy @JusTechne, @TiMinCeBIL, @IoannisLianos, @Elibietti, Marina Siqueira
1
2
1